Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2009
12/10/2009US20090304659 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+ t cells
12/10/2009US20090304658 Method of proliferating lak cell
12/10/2009US20090304655 Infant formula with probiotics
12/10/2009US20090304577 Peptides for Treatment and Diagnosis of Autoimmune Disease
12/10/2009DE19612966B4 MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren MDCK cells and methods for the propagation of influenza virus
12/10/2009CA2728772A1 Anti-cd8 antibodies block priming of cytotoxic effectors and lead to generation of regulatory cd8+t cells
12/10/2009CA2726804A1 Xbp1, cd138, and cs1 peptides
12/10/2009CA2723918A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance
12/09/2009EP2131198A2 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
12/09/2009EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009EP2130919A1 IL-21 antagonists
12/09/2009EP2130829A1 Novel hydroxyindole derivative
12/09/2009EP2130825A1 N-substituted thiomorpholine derivatives as the inhibitors of dipeptidyl peptidase iv and the pharmaceutical uses thereof
12/09/2009EP2130823A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
12/09/2009EP2130820A1 Antipruritics
12/09/2009EP2130547A1 IL-25 for use in the treatment of inflammatory diseases
12/09/2009EP2130541A2 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP2129692A2 Activation of human antigen-presenting cells through clec-6
12/09/2009EP2129690A1 Engineered anti-tslp antibody
12/09/2009EP2129379A1 Imidazoquinolines as dual lipid kinase and mtor inhibitors
12/09/2009EP2129216A1 Production of a viable, storable worm egg suspension
12/09/2009EP1732648B1 Treatment of diseases
12/09/2009EP1534819B1 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
12/09/2009EP1534286B1 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
12/09/2009EP1519939B1 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
12/09/2009EP1392642B1 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
12/09/2009EP1300401B1 Thiazole derivatives for use as antiinflammatories
12/09/2009EP1252144B1 Substituted glutarimides and use thereof il-12 production inhibitors
12/09/2009EP0959905B1 Polysaccharide-peptide-conjugates
12/09/2009CN101600693A Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases
12/09/2009CN101600456A Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
12/09/2009CN101600455A Prophylactic tuberculosis vaccine
12/09/2009CN101597612A SEC2 mutant gene with increased activity of super-antigen and preparation method thereof
12/09/2009CN101597337A Conjugate of hydroxyalkyl starch and an active agent
12/09/2009CN101597292A 2, 4, 6 substituent-pyridino-(3, 2-d) pyridine derivates and application thereof
12/09/2009CN101596309A Pharmaceutical composition for preventing and treating livestock and poultry viral disease and effervescing agent prepared by same
12/09/2009CN101596221A Process for preparing water-soluble ginkgo biloba extract used for injection
12/09/2009CN101596183A Echinacea oral liquid and preparation method thereof
12/09/2009CN101596177A Coenzyme Q10 self-emulsifying composition, preparation method and application thereof
12/09/2009CN101596001A Natural egg for activating blood and nourishing the heart and preparation method thereof
12/09/2009CN100567489C Antiallergic agent and pharmaceutical use thereof
12/09/2009CN100567275C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents
12/09/2009CN100567266C Cannabinoid receptor ligands
12/09/2009CN100566731C Qizhen capsule and Qizhen oral liquid for strengthening immunity
12/09/2009CN100566728C Method for extracting bitter buckwheat flavone in high purity
12/09/2009CN100566591C Bait used specially for atlantic trout
12/08/2009US7629477 mitotic kinesins like KSP inhibitors; for treating cellular proliferative diseases; N-(3-Aminopropyl)-N [(R)-1-3-benzyl-7-chloro-4-oxo-4H-chromen-2-yl)-2-methyl-propyl]-4-methyl-benzamide
12/08/2009US7629439 Peptides derived from the protein MMP-2, and the use thereof in antitumoral immunotherapy
12/08/2009US7629377 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
12/08/2009US7629375 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
12/08/2009US7629363 Diaryl substituted pyridinones
12/08/2009US7629350 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one
12/08/2009US7629337 Chemokine receptor binding heterocyclic compounds
12/08/2009US7629330 Use of zwitterionic polysaccharides for the specific modulation of immune processes
12/08/2009US7629324 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/08/2009US7629318 Immunosuppressant compounds, methods and uses related thereto
12/08/2009US7629313 Immunomodulatory polymeric antigens for treating inflammatory pathologies
12/08/2009US7629163 Methods for producing modified glycoproteins
12/08/2009US7629132 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer, apoptosis and autoimmune diseases
12/08/2009US7628990 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
12/08/2009US7628988 Induce cell differentiation; process control
12/08/2009US7628982 Boosting an immune response in an animal; vaccine containing B. subtilis spores, in the presence or absence of an antigen
12/08/2009CA2440744C Il-12 expression controlling agent
12/08/2009CA2422354C Pyrazole compounds useful as protein kinase inhibitors
12/08/2009CA2422342C Novel amide derivatives and medicinal use thereof
12/08/2009CA2415486C Pyramidine derivatives
12/08/2009CA2404725C Extrusion die
12/08/2009CA2399802C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/08/2009CA2370230C Treatment of systemic lupus erythematosis
12/08/2009CA2322845C Emulsion preconcentrates containing cyclosporin or a macrolide
12/08/2009CA2315113C Pyridones as src family sh2 domain inhibitors
12/08/2009CA2314613C Azolo triazines and pyrimidines
12/08/2009CA2218116C Pulmonary delivery of aerosolized medicaments
12/03/2009WO2009145989A2 Aminoalkylphenyl antagonists of prostaglandin d2 receptors
12/03/2009WO2009145690A1 Method and means for treating viral disease, in particular hiv/aids
12/03/2009WO2009145238A1 Immunomodulatory agent and use thereof
12/03/2009WO2009144720A1 Methods of treating inflammatory colon diseases
12/03/2009WO2009144494A1 Phenoxypyridinylamide derivatives and their use in the treatment of pde4 mediated disease states
12/03/2009WO2009144279A1 Method for the treatment or prophylaxis of chronic inflammatory diseases
12/03/2009WO2009144137A1 Probiotics to improve gut microbiota
12/03/2009WO2009144037A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009WO2009143944A2 Treatment of thromboangiitis obliterans by removal of autoantibodies
12/03/2009WO2009143865A1 Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
12/03/2009WO2009143816A1 Method for isolating cells and disease vectors from bodily fluids
12/03/2009WO2009143719A1 Herbal extracts which induce immune cells to produce interferon and activate toll-like receptors
12/03/2009WO2009143689A1 A soluble tumor necrosis factor receptor mutant
12/03/2009WO2009126877A3 Methods and compositions for accelerating the generation of regulatory tcells ex vivo
12/03/2009WO2009116088A3 Stem cell composition for inducing transplant tolerance
12/03/2009WO2009114085A3 Allogeneic cancer cell-based immunotherapy
12/03/2009WO2009098592A3 Preparation comprising mycobacterium bovis bcg killed by extended freeze drying (efd) for preventing or treating rheumatoid arthritis.
12/03/2009WO2009090651A3 Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
12/03/2009WO2009057079A3 Novel pyrimidine derivatives
12/03/2009WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections
12/03/2009WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
12/03/2009WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
12/03/2009US20090298939 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals
12/03/2009US20090298901 (e)-1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone oxime dihydrate and methods of its use
12/03/2009US20090298894 Amino acid compounds
12/03/2009US20090298886 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors
12/03/2009US20090298866 Indole Compounds
1 ... 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 ... 1172